Is Carcinoembryonic Antigen the Holy Grail for Pancreatic Cyst Risk Stratification?

참고문헌 (10)

1. de Jong K, "High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations", Clin Gastroenterol Hepatol, 8, pp.806~811 (2010)
2. Zerboni G, "Systematic review and meta-analysis : prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals", Pancreatology, 19, pp.2~9 (2019)
3. Brugge WR, "Diagnosis of pancreatic cystic neoplasms : a report of the cooperative pancreatic cyst study", Gastroenterology, 126, pp.1330~1336 (2004)
4. Cizginer S, "Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts", Pancreas, 40, pp.1024~1028 (2011)
5. Oppong KW, "EUS and EUS-FNA diagnosis of suspected pancreatic cystic neoplasms : is the sum of the parts greater than the CEA?", Pancreatology, 15, pp.531~537 (2015)
6. Ngamruengphong S, "Cyst carcinoembryonic antigen in differentiating pancreatic cysts : a meta-analysis", Dig Liver Dis, 45, pp.920~926 (2013)
7. Kaplan JH, "The use of biomarkers in the risk stratification of cystic neoplasms", Gastrointest Endosc Clin N Am, 28, pp.549~568 (2018)
8. Ibrahim Hakkı Köker, "Cyst Fluid Carcinoembryonic Antigen Level Difference between Mucinous Cystic Neoplasms and Intraductal Papillary Mucinous Neoplasms", Clinical Endoscopy, 54(1), pp.113~121 (2021), 대한소화기내시경학회[DOI]
9. Elta GH, "ACG clinical guideline : diagnosis and management of pancreatic cysts", Am J Gastroenterol, 113, pp.464~479 (2018)
10. European Study Group on Cystic Tumours of the Pancreas, "European evidence-based guidelines on pancreatic cystic neoplasms", Gut, 67, pp.789~804 (2018)